Rami Elghandour, President at NEVRO CORP (NVRO), sold 3,500 shares at $61.67 ($216K) on 2015-12-07, disclosed to the SEC on 2015-12-09.
Scheduled sale ($216k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.67 | 2,587 | $160K | 73.7% |
| 2 | $62.22 | 913 | $57K | 26.3% |
| Total | $61.81 avg | 3,500 | $216K | 100% |
| Filing → |
| ACLX | SELL | 2025-01-10 | $4.5M | — | Filing → |
| ACLX | SELL | 2025-01-10 | $4.7M | — | Filing → |
| ACLX | SELL | 2025-01-06 | $2.2M | — | Filing → |